Tamoxifen and endometrial cancer: from experiment to patient.
Assikis
V J
VJ
Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, IL 60611, USA.
Jordan
V C
VC
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000009:adverse effects*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen